10 likes | 136 Views
This study focuses on the fractions of GST-L1 in HPV16 samples, analyzing their distribution and total proportions. We present systematic data concerning various fractions (1 through 15) in relation to COPV and the percentage of total GST-L1 present in these samples, utilizing metrics such as A450 for quantification. The findings aim to enhance our understanding of GST-L1 behavior in HPV16, with implications for vaccine development and therapeutic strategies.
E N D
a COPV GST-L1 HPV16 GST-L1 D12345 GST-L1 FRACTIONS 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 P b D12345 GST-L1 4.5S 11S 19S % of total FRACTIONS 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 P COPV GST-L1 c 4.5S 11S 19S % of total d A450 g GST-L1